Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules.
暂无分享,去创建一个
Jürgen Läuter | Siegfried Kropf | Knut Krohn | Ralf Paschke | R. Paschke | S. Kropf | J. Läuter | M. Eszlinger | K. Krohn | D. Führer | M. Beck | Markus Eszlinger | Dagmar Führer | K. Berger | Martin Beck | Kerstin Berger
[1] R. Paschke,et al. Cold thyroid nodules show a marked increase in proliferation markers. , 2003, Thyroid : official journal of the American Thyroid Association.
[2] L. Reis,et al. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. , 2003, Cancer letters.
[3] Steven C. Lawlor,et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.
[4] J. Fagin,et al. Clonal composition of benign and malignant human thyroid tumors. , 1990, The Journal of clinical investigation.
[5] R. Paschke,et al. Ras mutations are rare in solitary cold and toxic thyroid nodules , 2001, Clinical endocrinology.
[6] W. R. Bishop,et al. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[7] J. Köhrle,et al. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. , 1994, The Journal of clinical endocrinology and metabolism.
[8] M. Fey,et al. Clonal Analysis of Human Tumors with M27,6, a Highly Informative Polymorphic X Chromosomal Probe , 2013 .
[9] J. Massagué,et al. Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage , 2002, Nature.
[10] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[11] R. Paschke,et al. BRAF Mutations Are Not an Alternative Explanation for the Molecular Etiology of ras -Mutation Negative Cold Thyroid Nodules , 2004 .
[12] S. Asa,et al. Clonality of thyroid nodules in sporadic goiter. , 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[13] A. V. Van Herle,et al. Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro. , 1990, The Journal of clinical endocrinology and metabolism.
[14] Charis Eng,et al. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. , 2003, Cancer research.
[15] S. S. Young,et al. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[16] L. Bachrach,et al. Phorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells. , 1985, Endocrinology.
[17] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] N. Takasu,et al. Tumour promoter 12-O-tetradecanoylphorbol 13-acetate and epidermal growth factor stimulate proliferation and inhibit differentiation of porcine thyroid cells in primary culture. , 1987, The Journal of endocrinology.
[19] A. Belfiore,et al. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine‐deficient area , 1987, Cancer.
[20] J. Köhrle,et al. Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[21] R. Paschke,et al. Gene expression analysis reveals evidence for inactivation of the TGF-β signaling cascade in autonomously functioning thyroid nodules , 2004, Oncogene.
[22] R. Baxter,et al. Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.
[23] Z. Kraiem,et al. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles. , 1995, Endocrinology.
[24] J. Richardson. EFFECTS 1 , 2022 .
[25] M. Stratton,et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. , 2002, Cancer research.
[26] A. Allgeier,et al. Mutation analysis of the Epac--Rap1 signaling pathway in cold thyroid follicular adenomas. , 2001, European journal of endocrinology.
[27] J. Parma,et al. The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.
[28] D. Segev,et al. Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia. , 1998, The Journal of clinical endocrinology and metabolism.
[29] D. Wynford‐Thomas,et al. RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation , 2000, Oncogene.
[30] J. Klose,et al. Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. , 1999, Methods in molecular biology.
[31] Guoying Liu,et al. NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..
[32] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[33] C. Esapa,et al. Prevalence of Ras mutations in thyroid neoplasia , 1999, Clinical endocrinology.
[34] B. Haye,et al. Tetradecanoyl phorbol-13-acetate counteracts the responsiveness of cultured thyroid cells to thyrotropin. , 1985, Biochemical pharmacology.
[35] S. Kropf,et al. Multivariate tests based on left-spherically distributed linear scores , 1998 .
[36] M. Donovan,et al. The cellular retinoic acid binding proteins , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[37] M. Gleave,et al. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. , 2000, Endocrinology.
[38] J. Dumont,et al. Stimulation of cell proliferation and inhibition of differentiation expression by tumor-promoting phorbol esters in dog thyroid cells in primary culture. , 1986, Cancer research.
[39] I. Roninson. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.
[40] Yuri E Nikiforov,et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.
[41] R. Paschke,et al. Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter. , 1999, The Journal of clinical endocrinology and metabolism.
[42] R. Paschke,et al. Complementary DNA expression array analysis suggests a lower expression of signal transduction proteins and receptors in cold and hot thyroid nodules. , 2001, The Journal of clinical endocrinology and metabolism.
[43] R. Duronio,et al. Histone mRNA expression: multiple levels of cell cycle regulation and important developmental consequences. , 2002, Current opinion in cell biology.
[44] S. Mohan,et al. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. , 1999, Endocrinology.
[45] M. Stratton,et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. , 1997, American journal of human genetics.
[46] R. Paschke,et al. Increased thyroid epithelial cell proliferation in toxic thyroid nodules. , 1999, Thyroid : official journal of the American Thyroid Association.
[47] C Eng,et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Berridge. Inositol trisphosphate and calcium signalling , 1993, Nature.
[49] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[50] P. Carayon,et al. Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. , 2003, Endocrinology.
[51] J. Puck,et al. Clonal analysis of solitary follicular nodules in the thyroid. , 1990, The American journal of pathology.
[52] R. Paschke,et al. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. , 2004, The Journal of clinical endocrinology and metabolism.
[53] A. de la Chapelle,et al. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma , 2003, International journal of cancer.
[54] J. Köhrle,et al. Retinoic acid redifferentiation therapy for thyroid cancer. , 2000, Thyroid : official journal of the American Thyroid Association.